5 HIV Treatment Strategies
What the common cold virus, stem cells, and phylogeny can do to save the millions of people living with HIV.
In 2006, 25 years after AIDS made its first appearance in the CDC's Morbidity and Mortality Weekly Report, an estimated 2.9 million people died of the illness. That same year, more than 4 million people were infected with HIV, joining the 35.2 million living with HIV/AIDS. Despite the dozens of approved treatments for the disease, resistance and side effects are never far behind, and millions of people need new therapies to help them live with HIV/AIDS, not die from it. On the next several pages, you'll find five approaches that researchers say could do just that, or even prevent the disease entirely.
One, the first oral treatment that prevents the virus from entering uninfected host cells (see "The best offense?"),...
Vaccines, whether used as treatments or for prevention, remain a hot area of research. On "A piggyback attack," , we describe how some scientists are using adenovirus to deliver HIV genes; on "Reconstructing early HIV," we tell the story of other researchers who are hoping that ancient strains of the virus will yield new immunogens.
Structural biologists will be pleased to learn that their discipline, by filling in the missing pieces of what happens as HIV invades the cell, could reveal a chink in the virus's armor (see "Solving the viral spike"). Stem cells have made their mark here, as well, as researchers try to transduce anti-HIV genes into T cells (see "Stem cells and gene therapy").
Whatever the drug delivery strategy within the body, the world still needs to come up with a strategy that delivers drugs to those who need them. The George W. Bush administration pledged $15 billion in spending to Africa from 2003 to 2008, and recently asked Congress to double that commitment to $30 billion from 2008 until 2013. "AIDS is no longer a death sentence for those who can get the medicines," former US president Bill Clinton once said. "Now it's up to the politicians to create the 'comprehensive strategies' to better treat the disease."
A piggyback attack: Using the common cold to deliver an HIV vaccine
The best offense? CCR5 inhibitors, with one now on the market, suggest it may be a good defense
Stem cells and gene therapy: Researchers take a second look at using stem cells to treat HIV
Solving the viral spike: Can structural biology find a chink in HIV's armor?
Reconstructing early HIV: The search for immunogens delves into the virus' past
Interested in reading more?
Become a Member of
